Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466953) titled 'Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality' on March 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Mert Ersan
Condition:
Skin Aging
Facial Aging
Skin Quality
Intervention:
Biological: Mesenchymal Stem Cell-Derived Exosome
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: April 1, 2026
Target Sample Size: 30
To know more, visit https://clinicaltrials.gov/study/NCT07466953
Published by HT Digital Conten...